NewInsight: Anthropic's IPO price against 48 tech IPOs since 1997

Hemab Therapeutics Holdings COAG

Hemab Therapeutics Holdings listed on Nasdaq on 1 May 2026 and is not in the S&P 500. It is worth $1.9 billion. Its board is not in our data yet. At 30 Jun 2026, Ra Capital Management was its largest institutional holder, with 16.7% of the company.

CEO
Benny Sorensen
Listed
1 May 2026 on Nasdaq, IPO filings and terms
Headquarters
Cambridge, MA
Market cap
$1.9B
19 Nov 2026 close
Revenue
-
No annual report yet

Board and leadership

Board and officers

Hemab Therapeutics Holdings' board is not in our data yet. It listed on 1 May 2026 and has not filed a proxy statement. See its 8-K filings.

Owners and trading

Largest institutional holders

Each fund group's share of Hemab Therapeutics Holdings. Where a company has several share classes, the share is of its total value.

13F filings for the quarter to 30 Jun 2026

These five hold 49.0% of Hemab Therapeutics Holdings.

Insider trades

Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.

Trades from 19 Nov 2025 to 19 Nov 2026

Directors and officers made no open-market sales and bought $52.2 million in 3 purchases in the 12 months to 19 Nov 2026.

DatePersonTitleTypeSharesValue
6 May 2026BuyPeter KolchinskyDirectorDirectorBuy68,018$1.7M
5 May 2026BuyPeter KolchinskyDirectorDirectorBuy97,411$2.4M
4 May 2026BuyPeter KolchinskyDirectorDirectorBuy2,675,000$48M

Timeline

Leadership changes, layoffs and insider sales

20 Nov 2024 to 20 Nov 2026; insider sales from 19 Nov 2025

1 departure and 1 appointment of directors and officers in the last two years.

Left the company or board 1Appointed 1WARN layoff notices 0Large insider sales 0Jan 2025AprJulOctJan 2026AprJulOct

Events, newest first

Not on file: no weekly market cap history, no trades disclosed by members of Congress or officials since November 2023, no WARN layoff notices under its own name or a listed subsidiary's since November 2023, no open roles from its careers site yet, no earnings release figures from the last six months and no quarterly results in its SEC XBRL filings.